One of the methods used for subgingival plaque control is a local drug delivery system into the periodontal pocket.
The purpose of this study was to compare the clinical effects of a newly designed Strip type Drug for Periodontitis (SDP) with minocycline hydrochloride dental ointment (Periocline ® : PER). SDP is a new degradable controlled release device containing Minocycline hydrochloride. SDP is formed as a strip type such that it is possible to ascertain whether the strip has reached the bottom of the pocket.
The patients participating in this study had chronic periodontitis with periodontal pockets exceeding 4 mm, but were free of systemic disease and had not been on antibiotic therapy within the preceding three months. SDP was applied in 33 cases and PER in 35. Both drugs were applied at baseline and at weeks 1, 2 and 3. Clinical evaluation was performed for 7 weeks, and microbiological evaluation was also performed at baseline and at weeks 4 using routine culture methods. The clinical variables used were clinical probing depth (PD), bleeding on probing (BOP), suppuration (5), plaque and gingival indices (PH, GI), and gingival crevicular fluid (GCF).
Porphyromonas gingivalis (
P. g.),
Prevotella intermedia (
P. i),
Prevotella melaninogenica (
P. m.),
Capnocytophaga spp. (
Cap.),
Actinobacillus actinomycetemcomitans (
A. a.),
Eikenella corrodens (
E. c.), and
Fusobacterium nucleatum (
F. n.) were isolated from the pockets using selective media, and Black Pigmented Gram-Negative Anaerobic Rods BPNAR) and total viable bacteria were meas u (red using non-selective media.
The following clinical results were obtained:
Significant reductions from baseline of BOP, S, GI and PD were observed in both groups at 3, 4 and 7 weeks, but a marked GCF reduction was observed only in the PER group. The rate of clinical improvement for each index between baseline and at each examination week was apparent in both groups, and no differences were observed between the two groups.
The following microbiological results were obtained:
Reductions in BPNAR and viable counts were observed between baseline and at 4 weeks, with no difference between two groups. Reductions in 7 pathogenic bacteria (
P. g.,
P.i.,
P. m.,
Cap.,
A. a.,
E. c. and
F. n.) were also significant between baseline and at 4 weeks in both groups.
From these results, it is clear that the newly designed local drug delivery system (SDP) effectively improves periodontal disease, with no major differences being observed between the strip type SDP) and the ointment type (PER).
View full abstract